IL135943A0 - Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof - Google Patents
Hyperthermic inducible expression vectors for gene theraphy and methods of use thereofInfo
- Publication number
- IL135943A0 IL135943A0 IL13594398A IL13594398A IL135943A0 IL 135943 A0 IL135943 A0 IL 135943A0 IL 13594398 A IL13594398 A IL 13594398A IL 13594398 A IL13594398 A IL 13594398A IL 135943 A0 IL135943 A0 IL 135943A0
- Authority
- IL
- Israel
- Prior art keywords
- hyperthermic
- methods
- expression vectors
- inducible expression
- gene theraphy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6408897P | 1997-11-03 | 1997-11-03 | |
PCT/US1998/023387 WO1999023216A2 (en) | 1997-11-03 | 1998-11-03 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135943A0 true IL135943A0 (en) | 2001-05-20 |
Family
ID=22053477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13594398A IL135943A0 (en) | 1997-11-03 | 1998-11-03 | Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1029041A2 (xx) |
JP (1) | JP2001521740A (xx) |
KR (1) | KR20010031762A (xx) |
CN (1) | CN1299411A (xx) |
AU (1) | AU1377299A (xx) |
BR (1) | BR9813917A (xx) |
CA (1) | CA2308575A1 (xx) |
IL (1) | IL135943A0 (xx) |
WO (1) | WO1999023216A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19951765A1 (de) * | 1999-10-27 | 2001-05-03 | Thomas Schweder | Wirts-Vektor-Systeme zur Überproduktion von thermolabilen Enzymen psychrophiler Organismen |
US6579522B1 (en) | 2000-06-27 | 2003-06-17 | Genvec, Inc. | Replication deficient adenoviral TNF vector |
US7285414B2 (en) | 2000-09-26 | 2007-10-23 | Emory University | Viruses targeted to hypoxic cells and tissues |
ATE418342T1 (de) * | 2000-09-26 | 2009-01-15 | Univ Emory | Viren gegen hypoxische zellen und gewebe |
US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
AU2003242459B2 (en) | 2002-06-18 | 2007-05-17 | Eisai R&D Management Co., Ltd. | Primary cultured adipocytes for gene therapy |
US20060015951A1 (en) * | 2002-10-14 | 2006-01-19 | Karsten Eulenberg | Proteins involved in the regulation of energy homeostasis |
JP2008048601A (ja) * | 2004-06-15 | 2008-03-06 | Nippon Kosei Kagaku Kenkyusho:Kk | 治療に有用な産物の生産法およびシステム |
JP2008540347A (ja) * | 2005-05-03 | 2008-11-20 | フェテリネールメディツィニシュ ウニベルジテート ウィーン | 浸透性カプセル |
CN101868241A (zh) * | 2007-09-28 | 2010-10-20 | 英特瑞克斯顿股份有限公司 | 表达生物治疗分子的治疗基因开关构建物和生物反应器以及它们的应用 |
CN103667345B (zh) * | 2013-12-02 | 2015-10-28 | 东南大学 | 一种抗肿瘤基因磁性复合纳米颗粒及制备方法 |
WO2017133175A1 (en) * | 2016-02-04 | 2017-08-10 | Nanjing Legend Biotech Co., Ltd. | Engineered mammalian cells for cancer therapy |
CN108913661A (zh) * | 2018-06-22 | 2018-11-30 | 安徽 | 一种人体研究用造血干细胞的制备和提取方法 |
CN114317588B (zh) * | 2020-09-29 | 2023-06-27 | 中国农业科学院生物技术研究所 | 一种作物高温响应型基因组精准甲基化调控回路 |
IT202200000788A1 (it) * | 2022-01-19 | 2023-07-19 | Bruno Cell S R L | Induzione sensibile alla temperatura del programma miogenico e/o adipogenico in cellule per la produzione di tessuto muscolare e/o adiposo |
CN116536349B (zh) * | 2023-05-22 | 2024-02-20 | 安徽农业大学 | 一种大豆GmMLP34基因在调控植物耐高温性上的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991770A (en) * | 1974-01-24 | 1976-11-16 | Leveen Harry H | Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation |
EP0299127A1 (en) * | 1987-07-16 | 1989-01-18 | IntraCel Corporation | A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
EP0455424A3 (en) * | 1990-05-02 | 1992-04-29 | Merck & Co. Inc. | Mammalian inducible promoter cascade system |
FR2717187B1 (fr) * | 1994-03-10 | 1996-05-31 | Transgene Sa | Usage combiné de deux cassettes d'expression pour la production d'une protéine d'intérêt. |
-
1998
- 1998-11-03 JP JP2000519075A patent/JP2001521740A/ja active Pending
- 1998-11-03 EP EP98957538A patent/EP1029041A2/en not_active Withdrawn
- 1998-11-03 AU AU13772/99A patent/AU1377299A/en not_active Abandoned
- 1998-11-03 WO PCT/US1998/023387 patent/WO1999023216A2/en not_active Application Discontinuation
- 1998-11-03 IL IL13594398A patent/IL135943A0/xx unknown
- 1998-11-03 CN CN98812752A patent/CN1299411A/zh active Pending
- 1998-11-03 BR BR9813917-7A patent/BR9813917A/pt not_active Application Discontinuation
- 1998-11-03 CA CA002308575A patent/CA2308575A1/en not_active Abandoned
- 1998-11-03 KR KR1020007004827A patent/KR20010031762A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2308575A1 (en) | 1999-05-14 |
CN1299411A (zh) | 2001-06-13 |
JP2001521740A (ja) | 2001-11-13 |
WO1999023216A3 (en) | 1999-08-05 |
WO1999023216A2 (en) | 1999-05-14 |
EP1029041A2 (en) | 2000-08-23 |
KR20010031762A (ko) | 2001-04-16 |
AU1377299A (en) | 1999-05-24 |
BR9813917A (pt) | 2001-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL135943A0 (en) | Hyperthermic inducible expression vectors for gene theraphy and methods of use thereof | |
EP1037911A4 (en) | ANTI-PATHOGEN SYSTEM AND METHOD FOR USE THEREOF | |
EP1418940A4 (en) | DNA expression vectors and methods of use | |
EP0704532A3 (en) | Recombinant chimeric proteins and methods of using them | |
HUP0003402A3 (en) | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use | |
HUP0003852A3 (en) | Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias | |
PL321201A1 (en) | Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives | |
PL110099U1 (en) | Pair of hairdresser's scisors | |
EP0960191A4 (en) | COMPOSITIONS AND METHODS FOR THE USE OF DEFENSIN | |
IL123716A0 (en) | New therapeutic combinations of mirtazepine and an antipsychotic agent | |
HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
EP0923642A4 (en) | AREAS OF SURVIVAL ACTIVITY OF THE INSULINIC GROWTH FACTOR I RECEPTOR (IGF-IR) AND TECHNIQUES OF USE | |
IL114331A0 (en) | Medical use of bromelain | |
AU4553793A (en) | Use of p97 and iron binding proteins as diagnostic and therapeutic agents | |
HK1031128A1 (en) | Jnk3 modulators and methods of use | |
AU6450398A (en) | Sr-bi regulatory sequences and therapeutic methods of use | |
IL129593A0 (en) | Novel constructs and vectors for the targeted and inducible expression of genes | |
EP1037669A4 (en) | THERAPEUTIC USE OF LENTIVIRAL VECTORS | |
HUP0000845A3 (en) | Process for the preparation of iodinated contrast agents and intermediates therefor | |
HUP9800146A3 (en) | Thalidomide-derivatives and use of them | |
AU3964499A (en) | Agouti-related protein analogs and methods of use | |
PL341599A1 (en) | Novel derivatives of p-aminophenol and their application | |
AU6720698A (en) | Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss | |
IL126757A0 (en) | Regulation of gene expression through manipulation of mRNA splicing and its uses | |
EP1070141A4 (en) | IMMEDIATE EARLY GENES AND METHODS OF USE |